chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Began with sore left arm which moved into the right arm around 3:00 pm.   Arms felt very heavy to lift and were sore.  Began chilling at about 4:00 pm.  Became very tired and went to bed at 8:00 pm.  Woke up around 1:00 am next morning and chills were gone,  Arms were still sore but did not feel as heavy.  By 10:00 am I was feeling perfectly normal.
Patient previously got the Modena COVID-19 at a different facility. He came to pharmacy for his 2nd dose but Pfizer COVID-19 was administered by mistake by the pharmacist.
Patient came  to the pharmacy on 04/27/2021 complaining that she had some redness and  swelling  at the site of the injection  a week after it was administered. After my observation, the site was swollen but the redness was no longer visible( patient had a picture of the redness from the previous night 04/26/21). Patient also said she took some Benadryl when she noticed the redness and swelling
Pt's mom called clinic on 8/21/17 and reported that patient's left shoulder swelled and became red/hot to touch. She took to PCP on 8/16/17 and PCP reported allergic to vaccine.
My twin sister tested positive, then my husband, I started showing symptoms, so I tested using a home COVID-19 test. It came back positive; I did not take anything for when I had COVID-19 as the symptoms were not bad but it did take twelve days before I tested negative. I then got influenza A, in the first part of March 2023, that lasted for a week. A month after getting over Influenza I got a cold and horrible cough. I was prescribed and inhaler with a steroid. I am currently using this medication, if the condition does not get better to come in to see him again.
Received tetanus 2/13/08 L deltoid - presents c/o localized soreness at site, pain continues and c/o L sided weakness in shoulder and discomfort with ROM and weight bearing of the left arm.  c/o weakness of L shoulder and arm day of vaccination and has not completely resolved at this time.
Patient's left arm is visibly red and swollen. It is warm and raised upon touching. Patient said she has some itching.
Pt received H1N1 inhaled on 1/6/10 with no reaction. On 1/8/10 itchy rash erupted on face, hands, feet, & body. Pt took BENADRYL at home with decreasing of redness & swelling which reduced after dose wore off. To clinic 1/12 rxd with Prednisone & hydroxyzine.
Folks vaccinated in December and January who have now caught covid; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of COVID-19 (Folks vaccinated in December and January who have now caught covid) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Folks vaccinated in December and January who have now caught covid). At the time of the report, COVID-19 (Folks vaccinated in December and January who have now caught covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant and  treatment medications were provided.
Red, swollen and very warm. We recommended Ice and BENADRYL. Follow up with Family Physician.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On unknown dates the patient was vaccinated with GARDASIL. On 07-OCT-2013 ("now") the patient was is the office to receive a third dose of GARDASIL which was off-schedule. No adverse events were reported. Additional information has been requested.
couldn't move her body at all; lay there unable to move or crawl or even pull herself up for 6-7 hours before she was discovered; no recollection of this episode of what happened to her or what she was doing at the time it occurred; she fell to her garage floor; speech was gargled; brain fog and difficulty; residual confusion; local reaction limited arm movement; local reactions such as pain; A spontaneous report was received from a consumer concerning a 77-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced local reactions such as pain and limited arm movement (vaccination site movement impairment/vaccination site pain), fell to garage floor (fall), couldn't move body at all (paralysis), lay there unable to move or crawl or even pull self up for 6-7 hours before discovered and taken to hospital (paralysis), brain fog and difficulty (feeling abnormal), no recollection of this episode of what happened or what she was doing at the time it occurred (amnesia), speech was gargled (dysarthria), and brain fog is improved now but still has some residual confusion (delirium).  The patient's medical history was not provided. Relevant concomitant medications were not reported.  On 27 FEB 2021, prior to the onset of events, the patient received their second dose of mRNA-1273 (lot/batch: unknown) intramuscularly in the right arm for prophylaxis of COVID-19 infection. On 27 FEB 2021, the patient experienced vaccination site movement impairment and vaccination site pain. On 28 FEB 2021, the patient experienced paralysis, amnesia, fall, dysarthria, and feeling abnormal and due to these events hospitalization was required. On 04 MAR 2021, the patient experienced Delirium.  Laboratory details was provided as CT Scan on 28 FEB 2021 and the result was normal. Treatment information was not provided.   The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) is not applicable.  At the time of this report, the outcome of the event's, local reactions such as pain and limited arm movement,fell to garage floor, couldn't move body at all , lay there unable to move or crawl or even pull self up for 6-7 hours before discovered and taken to hospital, brain fog and difficulty, no recollection of this episode of what happened or what she was doing at the time it occurred, speech was gargled, and brain fog is improved now but still has some residual confusion, were considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
it felt like she was punched in her arm for a couple days; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old female patient received BNT162b2 (BNT162B2), on 14Mar2021 as dose 1, single (Lot number: ER6208) at the age of 60 years intramuscular, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "it felt like she was punched in her arm for a couple days".  Additional information: It was reported that patient first dose of the two parter was on 14Mar2021, her vaccine card just has a sticker on the card and she can kind of barely read it, it says E something, she needs a magnifying glass. She had the vaccine card in her pocket for a while and now the sticker was hard to read. It said E then the next two are hard to read and then it said 6208. EXP wasn't provided on vaccine card. Second letter might be R. She was pretty sure the site for the injection was her arm because it felt like she was punched in her arm for a couple days. Her doses were probably given in her right arm, she doesn't remember and it was not written down, she was left handed so she wouldn't probably get it in that arm, she would get them in the other arm. Her second dose also has just a sticker on vaccine card. She got her initial shots, then two boosters, and then the bivalent . Patient did not received Prior Vaccinations within 4 weeks. No relevant test was reported. No Other Conditions and Investigations was reported.
Started about 5 hours after injection.  Muscle aches, headache, fever, chills, nausea, diarrhea, anxiety.  It?s been about  56 hours now after shot and I?m still experiencing side effects. Very close to how I felt January 15th, 2021 when I came down with Covid.
Severe dizziness and diarrhea that started 2 weeks after the vaccine first dose and to the date
Patient received the covid-19 vaccine, about 5 minutes after the patient starting having blurred vision, at this point the pharmacy staff was alerted and the emergency kit was taken to the patient.  The patient then started flushing and began swelling.  Patient's vitals were normal but she continued to swell showing significant signs of allergic reaction.  Patient was transported by ambulance to Hospital ER
Information has been received from a consumer concerning her friend's son who was vaccinated with a dose of MMR. Subsequently, the patient developed autism. Unspecified medical attention was sought. No product quality complaint was involved. Upon internal review, autism was determined to be an other important medical event (OMIC). No further information is available.
1st day: Low grade fever, body aches, tiredness.  2nd day: same as above with backaches, and under arm (injection site)lymph node pain 3rd day: backache, bone aches and under arm lymph node pain
I received both the flu shot and the pneumonia shot on the same day.  Pneumonia shot in left arm.  Flu shot in right arm. Left arm became swollen with severe pain from shoulder to elbow.  I was nauseous and dizzy.  Next day a little better.  3rd a little better etc.  Took some Tylenol.
Swelling occurred Lt arm at site of inj which required fluid aspiration on 9/4/12 by her physician pt could not lift arm up until 9/7/12 at which time she was totally recovered. Pt was sent for x-rays of left arm also for evaluation.
shingles; This initial spontaneous report was received on from a lawyer regarding a case in litigation and refers to a 77-year-old female patient. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On 23-APR-2012, the patient was vaccinated with a dose of zoster vaccine live (ZOSTAVAX) (the dosage regimen was not reported) for prophylaxis at a pharmacy/drug store. In September 2012, the patient suffered shingles (herpes zoster). As a result of her receipt of zoster vaccine live (ZOSTAVAX), the patient caused to suffer serious and dangerous side effects including shingles, as well as other severe personal injuries which were permanent and lasting in nature, physician pain and mental anguish including diminished enjoyment of life, the needed for lifelong medical treatment, monitoring and /or medication.  At the time of the report, the outcome of shingles (herpes zoster) was not recovered. The reporter considered the event previously mentioned to be related to Zoster Vaccine Live (ZOSTAVAX).
Patient fainted approx. 1 minute after getting the vaccine. Layed down on the floor with feet elevated  and head supported for 15 min after, given water and cold compress for forehead. No additional care needed
ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 7/19/2022 UNSPECIFIED ANXIETY  ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/18/2022 UNSPECIFIED ANXIETY  HYPOXIA 10/10/2022 UNSPECIFIED ANXIETY  ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 7/19/2022 ASPIRATION PNEUMONIA  ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/18/2022 ASPIRATION PNEUMONIA  HYPOXIA 10/10/2022 ASPIRATION PNEUMONIA  ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 7/19/2022 ATHEROSCLEROSIS OF AORTA    RIGHT ARM PAIN  ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/18/2022 ATHEROSCLEROSIS OF AORTA    RIGHT ARM PAIN  HYPOXIA 10/10/2022 ATHEROSCLEROSIS OF AORTA    RIGHT ARM PAIN
Swelling, red, soreness of Right arm. Said couldn't really move it much. Went twice to the doctor over next 7 days. Patient believes there is an infection in that arm.
Raised irregular rash (3 inches x 6 inches) on upper left arm around injection site; Rash was quite itchy but was not painful (potentially COVID arm); Severe headache; swollen gland in left side of neck (near clavicle); tiredness; aches; This is a spontaneous report from a non-contactable consumer (patient). A 48-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in left arm on 24Mar2021 11:45 (Lot Number: EL3247) (at the age of 48-years-old) as dose 2, single for covid-19 immunisation. Medical history included allergy to bees and mold. The patient received birth control and vitamins as concomitant medications within 2 weeks of vaccination. The patient previously took some antibiotics and experienced allergy. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in left arm on 03Mar2021 11:45 (Lot Number: EL3247) (at the age of 48-years-old) as dose 1, single for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 04:30, the patient experienced severe headache, swollen gland in left side of neck (near clavicle), tiredness and aches. On 27Mar2021 06:00, the patient had raised irregular rash (3 inches x 6 inches) on upper left arm around injection site; rash was quite itchy but was not painful (potentially COVID arm). The patient did not receive any treatment for the events. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a nurse refers to a patient of unknown age. The medical history, concurrent conditions and concomitant medications were no reported. On 03-NOV-2016, the patient was vaccinated with an expired dose of RECOMBIVAX HB lot # K014190, 24-OCT-2016 intramuscular. No adverse effect reported. Additional information has been requested.
DTaP, IPV given in left leg 11/22/06. Left upper leg red, edematous, tender, warm to touch. Tx: Benadryl and warm compresses
Tachycardia; patient was monitored and heart rate returned to normal; patient improved and went home. Patient was instructed to go to nearest ED if symptoms returned.
Hot flashes, sweat out breaks, body aches, joint aches, fatigue, nasal congestion, sore throat, pink eye
Patient's symptoms that family reported back included the development of the following over the next few weeks/months after vaccination: GI issues/GERD, upper respiratory issues, asthma-type symptoms/wheezing, eczema, food allergies (IgG allergy to peanuts), ear infections, speech delays, sensory food aversions (all vegetables and all but 2 fruits unless pureed), pooping blood and open bloody blisters up to his mid-back, potentially RSV and/or pneumonia.
patient received first dose of GARDASIL 9 at age 14 and second dose on 11/17/21 at age 17; This spontaneous report was received from an office administrator and refers to a 17-year-old patient of an unknown gender. No information regarding the patient's concurrent condition, medical history or concomitant medications was provided.  On an unknown date approximatelly in 2018, reported as when the patient was 14 years old, he was administered the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, frequency, route of adnimistration, lot # and expiration date were not reported) for prophylaxis. On 17-NOV-2021, the patient came into the office and received the secon dose of  hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis. The vaccines were not given at the recommended dose interval (Inappropriate schedule of vaccine administered).
diarrhea; This case was reported by a consumer via call center representative and described the occurrence of diarrhea in a 60-year-old male patient who received Flu Seasonal QIV Dresden (Fluarix Tetra 2020-2021 season) for prophylaxis.   Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   In November 2020, the patient received Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. In November 2020, less than a day after receiving Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced diarrhea. On an unknown date, the outcome of the diarrhea was recovered/resolved.   It was unknown if the reporter considered the diarrhea to be related to Fluarix Tetra 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The case was reported by patient's wife. The age at vaccination was not reported. The reporter stated patient experienced diarrhea after receiving Fluarix, in the first week of November 2020. The patient began experiencing diarrhea within 12 hours of receiving the vaccine. The reported stated diarrhea lasted at least 4 days, possibly longer. Consented to follow up.
This spontaneous report was received from a registered nurse refers to an approximately 11 month old patient(gender unspecified). No medical history was reported. On 19-AUG-1999 the patient was vaccinated with dose 1 (merck) VARIVAX ( lot#, expiry not reported), 0.5 ml, subcutaneously 9 days prior to first birthday. No concomitant medications were reported. On an unknown date in 2007, the patient was vaccinated with dose 2 of (merck) VARIVAX (lot # 658431/1184U, expiry:24-JUL-2009(reported as 29-JUL-2009)), 0.5 ml, subcutaneously. No adverse effects reported. Additional information has been requested.
Client complained of slight headache and seen by EMT.  Vital signs are 118/66, BS 118, HR 90, O2 98.  Client voice that she had not eaten but decrease was felt in symptom and client cleared to go home by EMT.
Fully vaccinated with Engerix B / Titers were low; This case was reported by a pharmacist via call center representative and described the occurrence of therapeutic response decreased in a 19-year-old female patient who received HBV (Engerix B) for prophylaxis.   Co-suspect products included HBV (Engerix B) for prophylaxis and HBV (Engerix B) for prophylaxis.   On an unknown date, the patient received the 1st dose of Engerix B, the 2nd dose of Engerix B and the 3rd dose of Engerix B. On an unknown date, unknown after receiving Engerix B, Engerix B and Engerix B, the patient experienced therapeutic response decreased. On an unknown date, the outcome of the therapeutic response decreased was unknown.   Additional details were reported as follows: This case was reported by a pharmacist. No patient's identifiers other than age and gender were provided. No lot number or expiration date provided. The reporter reported that the patient was fully vaccinated with Engerix B and to get into nursing school titers were measured. The titers were low and it was recommended to proceed with revaccination. Consented to follow up.
04/18/2022 vaccination 05/21/2022 I started to experience a scratchy throat. Frequent severe sneezing, coughing non-productive, scratchy throat, sinus infection, HA, stomach 'anorexic'.  05/22/2022 COVID+ *breakthrough COVID
Inflammation on left deltoid that appeared 8 days after 1st covid vaccine  measuring 8cm x 8 cm
Pt has 2nd dose of Pfizer vaccine today at approx 1037 and at within 5 min experienced nausea, palpitations and a metallic taste simuliar to copper pennies. She had breakfast at 0900 and had taken oral SL Zofran at 0930 due to previous reaction to the first vaccine where she had nausea, vomiited x 3 metallic taste and had to go home from work.  1055 had vomiting x 2 at present sitting in chair with legs elevated all VSS will list below.  1105 Spoke with Doctor and pt states she wants to go home. He said to offer her a Tryptase test to confirm a diagnosis of anaphylaxis. The Lab was called and the tests results take 5 to 7 days it is sent out to Lab.  Informed pt of the offer for testing and the time frame. 1117 Vomited for the third time and VSS are stable in recliner chair. 1125 Doctor informed pt wishes to go and sleep she is now starting to get a headache. She also does not wish to pursue the Tryptase test which she would have to go the urgent care to be seen and ordered.  Pt has a co-worker to drive her home and declines to go to Urgent care. She was instructed to return if her symptoms worsen.
Student broke out on Wednesday 2/1/06 during the evening at home. Stayed home until returning to school on 2/9/06. Mother reports less than 50 spots, no fever. Chicken pox.
convulsive reaction lasting 10-15 seconds approx 20 minutes to 1/2 hr p/receiving shot;
Mother brought in child on 04/20/17 at 11am to show this Nrsing superv. extension of the injectable site redness and swelling. Child is afebrile w/no other C/O any acute discomfort. (R) arm (upper deltoid is swollen and red 31/2 x 31/2). This Nrsg. Superv advised mom to apply Ice, NEOSPORIN to the skin and contact MD/PED or go to the nearest ED if gets worse. Nrsg. Superv. T.C. 4/21/17 mother reported much improvement w/Ice and NESPORIN ointment.
Patient is a 33 year old female who presents for vaccine site pain and swelling. Thursday 4/3/2014: No problems right after the shot was given. Friday 4/4/2014: she felt that she was under stress at work then and felt "just sore" on the left deltoid injection area, maybe a little warmth. That night though, she had difficulty sleeping due to the soreness on the left deltoid injection area; she was unable to lay on it, movements of the left arm would cause soreness. Saturday, woke up with tiredness and increased pain, warmth and tenderness on the left deltoid injection area. About 2/5 pain. The pain worsened later in the day with increased redness and swelling. She felt feverish but did not take temp. She iced the area. Sunday: she had persistent pain and soreness, redness and felt swollen in the left deltoid injection area. She took her temp: highest about 101F, less by the evening. She took Ibuprofen: 400 mg 4x a day since Saturday (after the 101F). Since then, continuing on the Ibuprofen, she had been feeling a little better, no fevers today (last ibuprofen was at 8 am); the redness and soreness have been less. No facial swelling, lip or tongue swelling; no swallowing or breathing problems. Patient denies cough, dyspnea, wheezing. No history of skin reactions to vaccinations. No respiratory allergies or asthma. No frequent skin rashes or dermatitis; no other new medications, foods, drinks, cosmetics, detergents, soaps.
can hardly raise right arm; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (can hardly raise right arm), HEADACHE (headache) and CHILLS (chills) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: SHINGRIX. Concurrent medical conditions included Allergy (ibuprofen allergy) and Allergy (tylenol allergy).    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced HEADACHE (headache) and CHILLS (chills). On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (can hardly raise right arm). At the time of the report, PAIN IN EXTREMITY (can hardly raise right arm), HEADACHE (headache) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact.